Anders Aagaard Rehfeld is a Postdoc at the University of Copenhagen's Department of Drug Design and Pharmacology, located at Jagtvej 160 in Copenhagen. His research focuses on reproductive biology and pharmacology, with particular emphasis on sperm function and calcium signaling pathways. His research interests center around the CatSper calcium channel in human sperm and how various compounds affect sperm function. He investigates the impact of pharmaceuticals, environmental chemicals, and natural compounds on male reproductive health. His work combines experimental pharmacology with reproductive biology to understand endocrine disruption mechanisms. Dr. Rehfeld's recent publications demonstrate a strong focus on how substances like paracetamol metabolites, pesticides, antidepressants, finasteride, and bisphenol analogs interact with sperm calcium signaling pathways. His research shows consistent patterns in examining chemical interference with the CatSper channel, which is crucial for sperm function and fertility. Scientific Recognition: PhD Cup 2018 Winner His collaborative work extends across multiple institutions in Copenhagen, particularly with Rigshospitalet researchers including Niels Skakkebæk, Anders Juul, and Katharina Main. His media presence includes an interview in Samvirke and a BRIDGE video interview in 2020, indicating engagement with both academic and public audiences. Dr. Rehfeld maintains an active research program with significant contributions to understanding environmental and pharmaceutical impacts on male reproductive health, particularly through the lens of calcium channel physiology in sperm cells.







